ClinicalTrials.Veeva

Menu

COGnitive ImpairmenT in Older HIV-infected Patients ≥ 65 Years Old (COGITO)

F

Fondation Ophtalmologique Adolphe de Rothschild

Status

Completed

Conditions

Cognitive Impairment
Memory Impairment
HIV/AIDS

Treatments

Other: assessment of cognitive impairment

Study type

Observational

Funder types

NETWORK

Identifiers

NCT03268109
AMR_2017_3

Details and patient eligibility

About

Despite combined antiretroviral therapy (cART), milder forms of HIV-associated neurocognitive disorders (HAND) persist in 20-50% of persons living with HIV (PLHIV). Since more PLH are at risk for HAND due to aging, the frequency of HAND in PLHIV ≥ 65 years old is important to quantify for planning early intervention to attenuate both functional and occupational disabilities due to cognitive impairment.

Enrollment

281 patients

Sex

All

Ages

65+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Personal or familial cognitive complaints
  • Individual aged ≥ 65 years old and < 81 years old
  • Instrumental activities of daily living (IADL) score between 3-4
  • French speaking individual
  • Informed consent signed For PLHIV
  • HIV infection
  • Undetectable HIV viral load ≥ 1 year
  • Current cluster of differentiation (CD4) cell count > 100/mm3 For controls
  • negative HIV serology ≤ 6 months

Exclusion criteria

  • Opportunistic infection < 5 years
  • Contraindications to MRI

Trial design

281 participants in 2 patient groups

people living with HIV
Description:
subjects infected with HIV and with cognitive complaints
Treatment:
Other: assessment of cognitive impairment
control subjects
Description:
subjects not infected with HIV and with cognitive complaints
Treatment:
Other: assessment of cognitive impairment

Trial contacts and locations

1

Loading...

Central trial contact

Amélie Yavchitz, MD, PhD; Lucia Lopes

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems